Biblio
Export 1991 results:
Author Title Type [ Year
Filters: First Letter Of Last Name is B [Clear All Filters]
“Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 59, no. 3, pp. 1017-1026, 2017.
, “Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 59, no. 3, pp. 1017-1026, 2017.
, “Reduction of RPT6/S8 (a Proteasome Component) and Proteasome Activity in the Cortex is associated with Cognitive Impairment in Lewy Body Dementia.”, J Alzheimers Dis, vol. 57, no. 2, pp. 373-386, 2017.
, “Reduction of RPT6/S8 (a Proteasome Component) and Proteasome Activity in the Cortex is associated with Cognitive Impairment in Lewy Body Dementia.”, J Alzheimers Dis, vol. 57, no. 2, pp. 373-386, 2017.
, “The Relationship between Markers of Inflammation and Degeneration in the Central Nervous System and the Blood-Brain Barrier Impairment in Alzheimer's Disease.”, J Alzheimers Dis, vol. 59, no. 3, pp. 903-912, 2017.
, “The Relationship of Brain Amyloid Load and APOE Status to Regional Cortical Thinning and Cognition in the ADNI Cohort.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1269-1282, 2017.
, “The Relationships Between Components of Metabolic Syndrome and Mild Cognitive Impairment Subtypes: A Cross-Sectional Study of Japanese Older Adults.”, J Alzheimers Dis, vol. 60, no. 3, pp. 913-921, 2017.
, “Relationships of Dietary Patterns, Foods, and Micro- and Macronutrients with Alzheimer's Disease and Late-Life Cognitive Disorders: A Systematic Review.”, J Alzheimers Dis, vol. 59, no. 3, pp. 815-849, 2017.
, “Relative Incidence of Seizures and Myoclonus in Alzheimer's Disease, Dementia with Lewy Bodies, and Frontotemporal Dementia.”, J Alzheimers Dis, vol. 60, no. 1, pp. 211-223, 2017.
, “Remyelination: A Potential Therapeutic Strategy for Alzheimer's Disease?”, J Alzheimers Dis, vol. 58, no. 3, pp. 597-612, 2017.
, “Risk Factors for Mild Cognitive Impairment in German Primary Care Practices.”, J Alzheimers Dis, vol. 56, no. 1, pp. 379-384, 2017.
, “Risk Factors, Neuroanatomical Correlates, and Outcome of Neuropsychiatric Symptoms in Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 2, pp. 483-493, 2017.
, “The Road Less Traveled: Alternative Pathways for Action-Verb Processing in Parkinson's Disease.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1429-1435, 2017.
, “The Road Less Traveled: Alternative Pathways for Action-Verb Processing in Parkinson's Disease.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1429-1435, 2017.
, “Role of Niemann-Pick Type C Disease Mutations in Dementia.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1249-1259, 2017.
, “Role of Niemann-Pick Type C Disease Mutations in Dementia.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1249-1259, 2017.
, “Screening for Alzheimer's Disease: Cognitive Impairment in Self-Referred and Memory Clinic-Referred Patients.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1621-1631, 2017.
, “Screening for Mild Cognitive Impairment and Dementia with Automated, Anonymous Online and Telephone Cognitive Self-Tests.”, J Alzheimers Dis, vol. 56, no. 1, pp. 249-259, 2017.
, “Selenium Levels in Serum, Red Blood Cells, and Cerebrospinal Fluid of Alzheimer's Disease Patients: A Report from the Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL).”, J Alzheimers Dis, vol. 57, no. 1, pp. 183-193, 2017.
, “Selenoprotein S Reduces Endoplasmic Reticulum Stress-Induced Phosphorylation of Tau: Potential Role in Selenate Mitigation of Tau Pathology.”, J Alzheimers Dis, vol. 55, no. 2, pp. 749-762, 2017.
, “Selenoprotein S Reduces Endoplasmic Reticulum Stress-Induced Phosphorylation of Tau: Potential Role in Selenate Mitigation of Tau Pathology.”, J Alzheimers Dis, vol. 55, no. 2, pp. 749-762, 2017.
, “Selenoprotein S Reduces Endoplasmic Reticulum Stress-Induced Phosphorylation of Tau: Potential Role in Selenate Mitigation of Tau Pathology.”, J Alzheimers Dis, vol. 55, no. 2, pp. 749-762, 2017.
, “Selenoprotein S Reduces Endoplasmic Reticulum Stress-Induced Phosphorylation of Tau: Potential Role in Selenate Mitigation of Tau Pathology.”, J Alzheimers Dis, vol. 55, no. 2, pp. 749-762, 2017.
, “Self-Consciousness Deficits in Alzheimer's Disease and Frontotemporal Dementia.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1437-1443, 2017.
, “Self-Consciousness Deficits in Alzheimer's Disease and Frontotemporal Dementia.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1437-1443, 2017.
,